The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Prevalence of smoking among psychiatric outpatients
Abstract
The prevalence of smoking among psychiatric outpatients (N = 277) was significantly higher than among either local or national population-based samples (N = 1,440 and 17,000) (52% versus 30% and 33%). The higher prevalence was not associated with the age, sex, marital status, socioeconomic status, alcohol use, coffee use, or institutionalization of the psychiatric patients. Smoking was especially prevalent among patients with schizophrenia (88%) or mania (70%) and among the more severely ill patients. Hypotheses about why psychiatric patients are more likely to smoke and why they do not have a high rate of smoking-induced illnesses are presented.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Second, tobacco dependence is highly prevalent in MDD populations (7) and MDD patients have a higher prevalence of smokers (8–10).”
From Persistent β 2 *-Nicotinic Acetylcholinergic Receptor Dysfunction in Major Depressive Disorder (2012) · cites this paper as [8]
Citations
Cites
Nonparametric statistics for the behavioral sciences
McGinn, L. C. (1957) · Journal of the Franklin Institute · doi:10.1016/0016-0032(57)90766-4 · Cited by 7,284
Social class and mental illness: Community study.
Hollingshead, A. B., & Redlich, F. C. (1958) · John Wiley & Sons, Inc. eBooks · doi:10.1037/10645-000 · Cited by 3,744
Social Class and Mental Illness: A Community Study
Hollingshead, A. B., & Redlich, F. C. (2007) · American Journal of Public Health · doi:10.2105/ajph.97.10.1756 · Cited by 1,846
Signs and Symptoms of Tobacco Withdrawal
Hughes, J. R. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800030107013 · Cited by 1,669
Self-citationTobacco, alcohol, and caffeine use: A review of their interrelationships.
Istvan, J. A., & Matarazzo, J. D. (1984) · Psychological Bulletin · doi:10.1037/0033-2909.95.2.301 · Cited by 485
Smoking, nicotine and human performance
Wesnes, K. A., & Warburton, D. M. (1983) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(83)90072-4 · Cited by 243
Paradoxical tranquilizing and emotion-reducing effects of nicotine.
Gilbert, D. G. (1979) · Psychological Bulletin · doi:10.1037/0033-2909.86.4.643 · Cited by 217
Depression, alcohol use, and smoking over one year: A four-wave longitudinal causal model.
Aneshensel, C. S., & Huba, G. J. (1983) · Journal of Abnormal Psychology · doi:10.1037//0021-843x.92.2.134 · Cited by 215
Mortality in a Follow-up of 500 Psychiatric Outpatients
Martin, R. L. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790240060006 · Cited by 211
Compliance with physician advice to quit smoking: A review of the literature
Pederson, L. L. (1982) · Preventive Medicine · doi:10.1016/0091-7435(82)90006-8 · Cited by 176
Flagged first, then by citations
Research works printed but not linked: 10
- Minnesota Depratment, 1983, Smoking: Health Risks
- Trends US, 1980, 1965 to
- Rassidakis NC, 1973, Agressologie, 14, 269
- Kessler II, 1978, Neurological Epidemiology, Principles and Clinical Applications: Advances in Neurology, vol 19
- Dawson GW, 1984, Vestal RE
- US Department of Health and Human Services, 1979, Smoking and Health-A Report of the Surgeon General: DHEW Publication PHS 79-5066
- Black DW, 1984, Iii: excess mortality among patients with "functional disorders.
- Tsuang MT, 1983, J Clin Psychiatry, 44, 42
- Levi RN, 1975, Schizophrenia, epilepsy, cancer, methionine and folate metabolism. Lancet 2:11-13
- Driscoll JS, 1978, Cancer Treat Rep, 62, 45
Cited by
Sorted by citations
Items 301–400 of 1,000
Cardiovascular risk factors in affective disorder
Yates, W. R., & Wallace, R. B. (1987) · Journal of Affective Disorders · doi:10.1016/0165-0327(87)90004-8 · Cited by 70
Foll, B. L., Mélihan-Cheinin, P., Rostoker, G., Lagrue, G., & for the working group of AFSSAPS (2005) · European Psychiatry · doi:10.1016/j.eurpsy.2004.12.008 · Cited by 73
Risk for Cancer in Parents of Patients With Schizophrenia
Dalton, S. O., Laursen, T. M., Mellemkjær, L., Johansen, C., & Mortensen, P. B. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.5.903 · Cited by 69
Nicotine reduces antisaccade errors in task impaired schizophrenic subjects
Larrison, A. L., MATORIN, A. A., & Sereno, A. B. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.01.002 · Cited by 69
Jarvis, M. J. (1994) · Addiction · doi:10.1111/j.1360-0443.1994.tb03732.x · Cited by 70
Elevated norharman plasma levels in alcoholic patients and controls resulting from tobacco smoking
Breyer-Pfaff, U., Wiatr, G., Stevens, I., Gaertner, H. J., Mundle, G., & Mann, K. F. (1996) · Life Sciences · doi:10.1016/0024-3205(96)00112-9 · Cited by 67
Does nicotine withdrawal affect smoking cessation? Clinical and theoretical issues
Patten, C. A., & Martin, J. E. (1996) · Annals of Behavioral Medicine · doi:10.1007/bf02883397 · Cited by 67
The effectiveness of nicotine-patch therapy for smoking cessation in patients with schizophrenia
Chou, K., Chen, R., Lee, J.-F., Ku, C., & Lu, R. (2003) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2003.07.001 · Cited by 67
Wojna, V., Robles, L., Skolasky, R. L., Mayo, R., Selnes, O. A., de la Torre, T., Maldonado, E., Nath, A., Meléndez, L. M., & Lasalde‐Dominicci, J. A. (2007) · Journal of NeuroVirology · doi:10.1080/13550280701620747 · Cited by 66
Social patterning of individual health behaviours: the case of cigarette smoking
(2005) · Social Determinants of Health · doi:10.1093/acprof:oso/9780198565895.003.11 · Cited by 68
Stein, J. A., Newcomb, M. D., & Bentler, P. M. (1996) · Journal of Applied Social Psychology · doi:10.1111/j.1559-1816.1996.tb01844.x · Cited by 66
Effect of nicotine use and withdrawal on brain preproenkephalin A mRNA
Houdi, A. A., Dasgupta, R., & Kindy, M. S. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00454-5 · Cited by 63
Allahverdipour, H., Abbasi-Ghahramanloo, A., Mohammadpoorasl, A., & Nowzari, P. (2015) · PubMed Central · Cited by 64
Effects of Nicotine on the Neurophysiological and Behavioral Effects of Ketamine in Humans
Mathalon, D. H., Ahn, K.-H., Perry, E. B., Cho, H. S., Roach, B. J., Blais, R. K., Bhakta, S. G., Ranganathan, M., Ford, J. M., & D’Souza, D. C. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00003 · Cited by 64
Evidence for a role of nicotinic acetylcholine receptors in schizophrenia
Catherine, E. A. (2007) · Frontiers in bioscience · doi:10.2741/2424 · Cited by 63
A CHRNA5 allele related to nicotine addiction and schizophrenia
Hong, L. E., Yang, X., Wonodi, I., Hodgkinson, C. A., Goldman, D. A., Stine, O. C., Stein, E. A., & Thaker, G. K. (2011) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2011.00689.x · Cited by 64
Cognitive Deficits in Schizophrenia: Focus on Neuronal Nicotinic Acetylcholine Receptors and Smoking
Ochoa, E. L. M., & Lasalde‐Dominicci, J. A. (2007) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-007-9149-x · Cited by 64
Smoking and Anxiety in Combat Veterans with Chronic Posttraumatic Stress Disorder: A Review
Beckham, J. C. (1999) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1999.10471731 · Cited by 64
Beckham, J. C., Lytle, B. L., Vrana, S. R., Hertzberg, M. A., Feldman, M. E., & Shipley, R. H. (1996) · Addictive Behaviors · doi:10.1016/0306-4603(95)00038-0 · Cited by 63
Nicotine and familial vulnerability to schizophrenia: A discordant twin study.
Lyons, M. J., Bar, J. L., Kremen, W. S., Toomey, R., Eisen, S. A., Goldberg, J. H., Faraone, S. V., & Tsuang, M. T. (2002) · Journal of Abnormal Psychology · doi:10.1037//0021-843x.111.4.687 · Cited by 62
Cigarette smoking in long-term schizophrenia
Salokangas, R. K. R., Honkonen, T., Stengård, E., Koivisto, A.-M., & Hietala, J. A. (2005) · European Psychiatry · doi:10.1016/j.eurpsy.2005.07.008 · Cited by 60
Strine, T. W., Edwards, V. J., Dube, S. R., Wagenfeld, M. O., Dhingra, S. S., Prehn, A. W., Rasmussen, S., McKnight-Eily, L. R., & Croft, J. B. (2012) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/1747-597x-7-30 · Cited by 67
Schulze, T. G., Schumacher, J. H., Müller, D. J., Krauß, H., Alfter, D., Maroldt, A., Ahle, G., Maroldt, A., y Fernández, A. N., Weber, T., et al. (2001) · American Journal of Medical Genetics · doi:10.1002/ajmg.1472 · Cited by 62
Effect of smoking on neuroleptics in schizophrenia
Salokangas, R. K. R., Saarijãrvi, S., Taiminen, T. J., Lehto, H., Niemi, H., Ahola, V., & Syvälahti, E. K. G. (1997) · Schizophrenia Research · doi:10.1016/s0920-9964(96)00083-7 · Cited by 62
Leventhal, A. M., Kahler, C. W., Ray, L. A., & Zimmerman, M. A. (2008) · Addictive Behaviors · doi:10.1016/j.addbeh.2008.11.008 · Cited by 61
Primack, B. A., Land, S. R., Fan, J., Kim, K. H., & Rosen, D. (2013) · Substance Use & Misuse · doi:10.3109/10826084.2012.750363 · Cited by 69
Morris, C. D., Waxmonsky, J. A., May, M. G., Tinkelman, D. G., Dickinson, M., & Giese, A. A. (2011) · Community Mental Health Journal · doi:10.1007/s10597-011-9411-z · Cited by 61
Lower β2*-Nicotinic Acetylcholine Receptor Availability in Smokers With Schizophrenia
D’Souza, D. C., Esterlis, I., Carbuto, M., Krasenics, M., Seibyl, J. P., Bois, F., Pittman, B. P., Ranganathan, M., Cosgrove, K., & Staley, J. K. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11020189 · Cited by 62
Goodwin, R. D., Zvolensky, M. J., & Keyes, K. M. (2008) · Psychological Medicine · doi:10.1017/s0033291708003012 · Cited by 61
Asharani, P. V., Seet, V. A. L., Abdin, E., Devi, F., Wang, P., Roystonn, K., Lee, Y. Y., Cetty, L., Teh, W. L., Verma, S. K., et al. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17155571 · Cited by 65
Smoking and cognitive deficits in schizophrenia: a pilot study
Taiminen, T. J., Salokangas, R. K. R., Saarijãrvi, S., Niemi, H., Lehto, H., Ahola, V., & Syvälahti, E. K. G. (1998) · Addictive Behaviors · doi:10.1016/s0306-4603(97)00028-2 · Cited by 61
Thorsteinsson, H. S. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00217-7 · Cited by 61
Antidepressant Medications and Risk for Cancer
Dalton, S. O., Johansen, C., Mellemkjær, L., Sørensen, H. T., McLaughlin, J. K., Olsen, J., & Olsen, J. H. (2000) · Epidemiology · doi:10.1097/00001648-200003000-00015 · Cited by 61
(2015) · Australasian Psychiatry · doi:10.1177/1039856214565568 · Cited by 58
Lev‐Ran, S., Imtiaz, S., Rehm, J. T., & Foll, B. L. (2013) · American Journal on Addictions · doi:10.1111/j.1521-0391.2013.00304.x · Cited by 62
Bupropion for the Treatment of Tobacco Dependence
Hays, J. T., & Ebbert, J. O. (2003) · CNS Drugs · doi:10.2165/00023210-200317020-00001 · Cited by 60
Smoking in First-Episode Patients With Schizophrenia
McEvoy, J. P., & Brown, S. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.7.1120a · Cited by 60
George, T. P., Verrico, C. D., Picciotto, M. R., & Roth, R. H. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38869-x · Cited by 62
Nicotinic Receptor Contributions to Smoking: Insights from Human Studies and Animal Models
Brunzell, D. H., Stafford, A. M., & Dixon, C. I. (2015) · Current Addiction Reports · doi:10.1007/s40429-015-0042-2 · Cited by 58
Clinical Aspects of Substance Abuse in Persons with Schizophrenia
Negrete, J. C. (2003) · The Canadian Journal of Psychiatry · doi:10.1177/070674370304800104 · Cited by 59
Glynn, S. M., & Sussman, S. Y. (1990) · Psychiatric Services · doi:10.1176/ps.41.9.1027 · Cited by 59
Parrott, A. C. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0294-y · Cited by 59
Gray matter volume differences and the effects of smoking on gray matter in schizophrenia
Tregellas, J. R., Shatti, S., Tanabe, J., Martín, L., Gibson, L., Wylie, K. P., & Rojas, D. C. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.08.019 · Cited by 58
Li, X.-H., An, F., Ungvari, G. S., Ng, C. H., Chiu, H. F. K., Wu, P.-P., Jin, X., & Xiang, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-07928-9 · Cited by 59
Individual differences in difficulty quitting smoking
HAJEK, P. (1991) · British Journal of Addiction · doi:10.1111/j.1360-0443.1991.tb01807.x · Cited by 58
Stevens, K. E., Meltzer, J., & Rose, G. M. (1995) · Psychopharmacology · doi:10.1007/bf02246157 · Cited by 58
Effect of Nicotine on Dynamic Function of Brain Catecholamine Neurons
Svensson, T. H., Grenhoff, J., & Engberg, G. (2007) · Novartis Foundation symposium · doi:10.1002/9780470513965.ch10 · Cited by 57
Jonathan Flint, C., & Munafo, M. R. (2014) · Nature · doi:10.1038/nature13645 · Cited by 57
Tanabe, J., Tregellas, J. R., Martín, L., & Freedman, R. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.004 · Cited by 57
Johnson, K. A., Farris, S. G., Schmidt, N. B., Smits, J. A. J., & Zvolensky, M. J. (2012) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntr332 · Cited by 57
A comparison of smoking behaviours between patients treated with clozapine and depot neuroleptics
Procyshyn, R. M., Ihsan, N., & Thompson, D. (2001) · International Clinical Psychopharmacology · doi:10.1097/00004850-200109000-00007 · Cited by 57
Prochaska, J. J., Reyes, R. S., Schroeder, S. A., Daniels, A. S., Doederlein, A., & Bergeson, B. (2011) · Bipolar Disorders · doi:10.1111/j.1399-5618.2011.00944.x · Cited by 56
Clarke, D. E., Eaton, W. W., Petronis, K. R., Ko, J. Y., Chatterjee, A. K., & Anthony, J. C. (2010) · Suicide and Life-Threatening Behavior · doi:10.1521/suli.2010.40.4.307 · Cited by 56
Zhang, X., Stein, E. A., & Hong, L. E. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.06.018 · Cited by 56
Hawken, E. R., Crookall, J. M., Reddick, D., Millson, R. C., Milev, R. V., & Delva, N. J. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.09.029 · Cited by 56
Colsher, P. L., Wallace, R. B., Pomrehn, P. R., LaCroix, A. Z., Cornoni‐Huntley, J. C., Blazer, D. G., Scherr, P. A., Berkman, L. F., & Hennekens, C. H. (1990) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(18)31026-2 · Cited by 56
Schizophrenia and tobacco smoking in a Spanish psychiatric hospital
LLerena, A., DELARUBIA, A., Peñas‐Lledó, E., Díaz, F. J., & DELEON, J. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00327-9 · Cited by 56
Morisano, D., Wing, V. C., Sacco, K. A., Arenovich, T., & George, T. P. (2013) · American Journal on Addictions · doi:10.1111/j.1521-0391.2013.00313.x · Cited by 57
Morris, C. D., Waxmonsky, J. A., May, M. G., & Giese, A. A. (2009) · Psychiatric Rehabilitation Journal · doi:10.2975/32.4.2009.276.284 · Cited by 55
Health Behaviors among Individuals with Schizophrenia and Depression
Leas, L., & McCabe, M. P. (2007) · Journal of Health Psychology · doi:10.1177/1359105307078162 · Cited by 59
Successful Tobacco Dependence Treatment in Schizophrenia
Williams, J. M., & Foulds, J. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.2.222 · Cited by 55
Depression and Smoking across 25 Years of the Normative Aging Study
Kinnunen, T., Haukkala, A., Korhonen, T., Quiles, Z. N., Spiro, A., & Garvey, A. J. (2006) · The International Journal of Psychiatry in Medicine · doi:10.2190/g652-t403-73h7-2x28 · Cited by 55
Smoking Status and Quality of Life
Mitra, M., Chung, M.-C., Wilber, N., & Walker, D. K. (2004) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2004.06.002 · Cited by 55
Lower Plasma Levels of Haloperidol in Smoking Than in Nonsmoking Schizophrenic Patients
Shimoda, K., Someya, T., Morita, S., Hirokane, G., Noguchi, T., Yokono, A., Shibasaki, M., & Takahashi, S. (1999) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199906000-00006 · Cited by 55
Clinical Experience With the Management of Schizophrenia in the General Hospital
Freudenreich, O., & Stern, T. A. (2003) · Psychosomatics · doi:10.1176/appi.psy.44.1.12 · Cited by 54
Williams, J. M., Steinberg, M. L., Zimmermann, M. H., Gandhi, K. K., Stipelman, B. A., Budsock, P. D., & Ziedonis, D. M. (2010) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2010.03.006 · Cited by 57
Smoking Habits in Bipolar and Schizophrenic Outpatients in Southern Israel
Itkin, O., Nemets, B., & Einat, H. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n0409 · Cited by 54
Carosella, A. M., Ossip-Klein, D. J., & Owens, C. A. (1999) · Addictive Behaviors · doi:10.1016/s0306-4603(98)00096-3 · Cited by 54
Kedzior, K. K., & Martin-Iverson, M. T. (2006) · Journal of Psychopharmacology · doi:10.1177/0269881105057516 · Cited by 54
Numata, S., Kinoshita, M., Tajima, A., Nishi, A., Imoto, I., & Ohmori, T. (2015) · BMC Medical Genetics · doi:10.1186/s12881-015-0197-7 · Cited by 55
Kodesh, A., Goldshtein, I., Gelkopf, M., Goren, I., Chodick, G., & Shalev, V. (2012) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-012-0478-9 · Cited by 53
Kelly, D. L., Raley, H., Lo, S., Wright, K., Liu, F., McMahon, R. P., Moolchan, E. T., Feldman, S. M., Richardson, C. M., Wehring, H. J., et al. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq124 · Cited by 53
Semba, J., Wakuta, M., Maeda, J., & Suhara, T. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(03)00024-6 · Cited by 53
Smoking impact on CYP1A2 activity in a group of patients with schizophrenia
Bozikas, V. P., Papakosta, M., Niopas, I., Karavatos, A., & Mirtsou-Fidani, V. (2003) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(03)00061-0 · Cited by 53
Combs, D. R., & Advokat, C. D. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00026-8 · Cited by 54
Patterns of depressive symptomatology in women smokers, ex-smokers, and never-smokers
Pomerleau, C. S., Zucker, A. N., & Stewart, A. J. (2003) · Addictive Behaviors · doi:10.1016/s0306-4603(01)00257-x · Cited by 52
Kumari, V., Aasen, I., Ffytche, D. H., Williams, S., & Sharma, T. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.08.013 · Cited by 50
Mortality in psychiatric patients 5 to 21 years after hospital admission in Italy
Politi, P., Piccinelli, M. P., Klersy, C., MADINI, S., Lusignani, G. S., Fratti, C., & Barale, F. (2002) · Psychological Medicine · doi:10.1017/s0033291701005116 · Cited by 51
Delay discounting and task performance consistency in patients with schizophrenia
Weller, R. E., Avsar, K. B., Cox, J. E., Reid, M. A., White, D. M., & Lahti, A. C. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2013.11.013 · Cited by 54
Amitai, N., & Markou, A. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1246-0 · Cited by 53
Weinberger, A. H., Sacco, K. A., Creeden, C. L., Vessicchio, J. C., Jatlow, P. I., & George, T. P. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2006.12.007 · Cited by 50
Addiction and the kynurenine pathway: A new dancing couple?
Morales‐Puerto, N., Giménez‐Gómez, P., Pérez‐Hernández, M., Abuin-Martínez, C., de Biedma‐Elduayen, L. G., Vidal, R., Gutiérrez‐López, M. D., O’Shea, E., & Colado, M. I. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107807 · Cited by 54
Gender and the use of neuroleptics in schizophrenia further testing of the oestrogen hypothesis
Salokangas, R. K. R. (1995) · Schizophrenia Research · doi:10.1016/0920-9964(94)00059-h · Cited by 50
Horst, W. D., Klein, M. W., Williams, D. D., & Werder, S. (2005) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.a802 · Cited by 49
Saules, K. K., Schuh, L. M., Arfken, C. L., Reed, K., Kilbey, M. M., & Schuster, C. R. (2004) · American Journal on Addictions · doi:10.1080/10550490490512762 · Cited by 49
Rezvani, A. H., Eddins, D. M., Slade, S. K., Hampton, D., Christopher, N. C., Petro, A. E., Horton, K., Johnson, M. L., & Levin, E. D. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.04.020 · Cited by 50
Kantrowitz, J. T., Javitt, D. C., Freedman, R., Sehatpour, P., Kegeles, L. S., Carlson, M., Sobeih, T. M., Wall, M. M., Choo, T.-H. J., Vail, B., et al. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0628-9 · Cited by 49
Solty, H., Crockford, D. N., White, W. D., & Currie, S. R. (2009) · The Canadian Journal of Psychiatry · doi:10.1177/070674370905400107 · Cited by 51
Smoking a single cigarette does not produce a measurable reduction in brain MAO B in non-smokers
Fowler, J. S., Wang, G., Volkow, N. D., Franceschi, D., Logan, J., Pappas, N. R., Shea, C. E., MacGregor, R. R., & Garza, V. (1999) · Nicotine & Tobacco Research · doi:10.1080/14622299050011451 · Cited by 49
Depressive symptomatology and smoking among persons with diabetes
Haire-Joshu, D. L., Heady, S., Thomas, L. V., Schechtman, K. B., & Fisher, E. B. (1994) · Research in Nursing & Health · doi:10.1002/nur.4770170406 · Cited by 49
The pharmacotherapy of smoking cessation
Peters, M. J., & Morgan, L. C. (2002) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2002.tb04521.x · Cited by 49
Influence of negative affect on smoking cessation treatment outcome: a pilot study
Rausch, J. L., NICHINSON, R., Lamke, C., & Matloff, J. L. (1990) · British Journal of Addiction · doi:10.1111/j.1360-0443.1990.tb03723.x · Cited by 49
Predictors of Early Abstinence in Smokers With Schizophrenia
Maravić, M. C., Schoenfeld, D., Barr, R. S., Cather, C., Deckersbach, T., Freudenreich, O., GOFF, D. C., Rigotti, N. A., & Evins, A. E. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n1109 · Cited by 48
Smoking in a forensic psychiatric service: a survey of inpatients’ views
Dickens, G. L., Stubbs, J. H., POPHAM, R., & Haw, C. (2005) · Journal of Psychiatric and Mental Health Nursing · doi:10.1111/j.1365-2850.2005.00892.x · Cited by 48
Role of the Central Cholinergic System in the Therapeutics of Schizophrenia
Terry, A. V. (2008) · Current Neuropharmacology · doi:10.2174/157015908785777247 · Cited by 48
Synthesis and biological activities of indolizine derivatives as alpha-7 nAChR agonists
Xue, Y., Tang, J., Ma, X., Li, Q., Xie, B., Hao, Y., Jin, H., Wang, K., Zhang, G., Zhang, L., et al. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.03.016 · Cited by 47
Phillips, J. M., Ehrlichman, R. S., & Siegel, S. J. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.11.003 · Cited by 47
Nicotine Interventions with Comorbid Populations
Hall, S. M. (2007) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2007.09.004 · Cited by 46
Varenicline for smoking cessation in people with schizophrenia: systematic review and meta-analysis
Kishi, T., & Iwata, N. (2014) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-014-0551-3 · Cited by 46
Johnson, J. L., Ratner, P. A., Malchy, L. A., Okoli, C. T. C., Procyshyn, R. M., Bottorff, J. L., Groening, M., Schultz, A. S. H., & Osborne, M. (2010) · BMC Psychiatry · doi:10.1186/1471-244x-10-101 · Cited by 46
Metadata
- Authors
- Hughes, J. R., Hatsukami, D. K., Mitchell, J. E., & Dahlgren, L.
- Affiliations
- University of Minnesota (US)
- Venue
- American Journal of Psychiatry
- Published
- 1986-08-01
- Volume
- 143
- Issue
- 8
- Pages
- 993-997
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W152718690
- Cited by
- 1,058
- References
- 44
- Citations by year
- 2026: 1 · 2025: 10 · 2024: 4 · 2023: 9 · 2022: 7 · 2021: 8 · 2020: 13 · 2019: 10 · 2018: 13 · 2017: 18 · 2016: 23 · 2015: 20 · 2014: 26 · 2013: 31 · 2012: 45
- FWCI
- 8.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Drug Abuse (DA-03728, DA 02988, DA-04066)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Keywords
- smoking prevalence, psychiatric outpatients, schizophrenia, mania, disease severity, alcohol consumption, socioeconomic status, smoking-related diseases
- MeSH terms
- Smoking Prevention, Adult, Ambulatory Care, Mental Disorders, Bipolar Disorder, Cross-Sectional Studies, Female, Hospitalization, Humans, Male, Middle Aged, Schizophrenic Psychology, Smoking
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review